maladies – Prise en charge de certains produits pour les femmes ayant un cancer du sein

This written question concerns the management of certain products for women diagnosed with breast cancer. It seeks clarification on the current approach and potential improvements in care. The question is posed by a Member of Parliament and is relevant to patients, healthcare providers, and the pharmaceutical industry involved in cancer treatment.